NVIDIA Corp.

Institutional investor · Portfolio as of Q2 2026

Q2 2026 biggest moves

Reported value$18.4B → $63.4B

  • SPCXSPCX

    SpaceX

    New listing

    33% of portfolio

1 change in all

Top Holdings8 positions

Checking export access…
Activity:
INTC

Intel Corporation

214.8M$30B47.3%$36.90+278.40%
3 qtrssince 2025-Q4
Unchanged
0
SPCX

Space Exploration Technologies Corp.

122.8M$21B33.1%$170.860.00%
1 qtr
New
Unranked
CRWV

CoreWeave, Inc.

47.2M$4.7B7.4%$56.95+74.77%
6 qtrssince 2025-Q1
Unchanged
0
COHR

Coherent Corp.

7.8M$3.1B4.8%$238.21+65.60%
2 qtrssince 2026-Q1
Unchanged
0
NOK
NOK
ADR

Nokia Corporation Sponsored

166.4M$2.2B3.5%$6.47+105.26%
3 qtrssince 2025-Q4
Unchanged
0
SNPS

Synopsys, Inc.

4.8M$2.2B3.4%$469.72-5.03%
3 qtrssince 2025-Q4
Unchanged
0
NBIS

Nebius Group N.V.

1.2M$328.8M0.5%$27.70+897.00%
7 qtrssince 2024-Q4
Unchanged
0
GENB

Generate Biomedicines, Inc.

833,325$14.1M0.0%$12.50+34.96%
2 qtrssince 2026-Q1
Unchanged
0
$63.4B
AUM
8
Positions
Q2 2026
Filing
HI rating · 2.5/5
Quarterly 13F Value Change
Reported 13F value ($B)
Reported 13F values and quarter-over-quarter reported value changes; not investment returns.
QuarterReported value in US dollarsReported value change
2025-Q1$1,147,142,107276.699173464%
2025-Q2$4,333,080,800277.728336669%
2025-Q3$3,843,681,339-11.2944919236%
2025-Q4$13,104,819,528240.944484524%
2026-Q1$18,374,354,15040.2106615108%
2026-Q2$63,439,974,569245.263697712%
Activity profile
$ moved · Q2'26
New100%Increased0%Decreased0%Exited0%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.4 quarters
<1Q13%1-4Q63%1-2Y25%2Y+0%

NVIDIA Corp. manages $63.4B across 8 positions as of Q2 2026. Top holdings: INTC (47.3%), SPCX (33.1%), CRWV (7.4%). Fund DNA: Concentrated Value. HoldingsIntel Score: 2.5/5.0.

Top holdings by portfolio weight

Total AUM$63B
INTC47.27%
SPCX33.06%
CRWV7.41%
COHR4.84%
NOK3.48%
SNPS3.39%
NBIS0.52%
GENB0.02%

Portfolio allocation by GICS sector

Sectors2
Technology99.23%
Communication Services0.77%

Behavioral investing profile

Checking access…
Concentrated Value- primarily Technology
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Solid(2.5 / 5.0)
Holdings P&L50
Conviction84
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Photo credits

Photo:“Warren Buffett at the 2015 SelectUSA Investment Summit”by USA International Trade Administration, cropped,public domainvia Wikimedia Commons

Photo:Leopold Aschenbrenner

Photo:“Cathie Wood ARK Invest Photo”by Caroline Wood, cropped,CC BY-SA 4.0via Wikimedia Commons

Photo:“Valeant Pharmaceuticals' Business Model (headshot)”by Senate Democrats, cropped,CC BY 2.0via Wikimedia Commons

Photo:Harlem Children's Zone

Photo:Mohnish Pabrai

Photo:“Peter Thiel on March 5 2026”by Kantei (The Prime Minister Office of Japan), cropped,CC BY 4.0via Wikimedia Commons

Photo:Charlotte FC

Photo:Ray Dalio

Photo:Himalaya Capital

Photo:Jonathan Kozowyk, Robin Hood

Photo:“Brad Gerstner at the White House 2025 (54581192563)”by The White House, cropped,public domainvia Wikimedia Commons

Photo:SuperReturn North America

Photo:Liz Linder, Harvard Kennedy School

Photo:Oaktree Capital Management

Photo:The Everglades Foundation

Photo:George Soros

Photo:Benjamin Meaker, Point72

Photo:Fundsmith

Photo:“Kenneth C. Griffin photo”by Paul Elledge, cropped,CC BY-SA 4.0via Wikimedia Commons

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Optional analytics helps us improve. How it’s used